AU2003235931A1 - Vintoperol-containing medicinal composition for transdermal administration - Google Patents

Vintoperol-containing medicinal composition for transdermal administration

Info

Publication number
AU2003235931A1
AU2003235931A1 AU2003235931A AU2003235931A AU2003235931A1 AU 2003235931 A1 AU2003235931 A1 AU 2003235931A1 AU 2003235931 A AU2003235931 A AU 2003235931A AU 2003235931 A AU2003235931 A AU 2003235931A AU 2003235931 A1 AU2003235931 A1 AU 2003235931A1
Authority
AU
Australia
Prior art keywords
vintoperol
transdermal administration
medicinal composition
containing medicinal
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003235931A
Inventor
Taku Ito
Minoru Iwatsu
Masuo Murakami
Isao Serizawa
Hiroki Takada
Junko Yamada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takata Pharmaceutical Co Ltd
Original Assignee
Takata Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takata Pharmaceutical Co Ltd filed Critical Takata Pharmaceutical Co Ltd
Publication of AU2003235931A1 publication Critical patent/AU2003235931A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
AU2003235931A 2002-05-13 2003-05-12 Vintoperol-containing medicinal composition for transdermal administration Abandoned AU2003235931A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002-136990 2002-05-13
JP2002136990 2002-05-13
PCT/JP2003/005867 WO2003094917A1 (en) 2002-05-13 2003-05-12 Vintoperol-containing medicinal composition for transdermal administration

Publications (1)

Publication Number Publication Date
AU2003235931A1 true AU2003235931A1 (en) 2003-11-11

Family

ID=29416802

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003235931A Abandoned AU2003235931A1 (en) 2002-05-13 2003-05-12 Vintoperol-containing medicinal composition for transdermal administration

Country Status (3)

Country Link
JP (1) JPWO2003094917A1 (en)
AU (1) AU2003235931A1 (en)
WO (1) WO2003094917A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005267396B2 (en) * 2004-06-24 2009-09-17 Idexx Laboratories, Inc. Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same
ITMI20060712A1 (en) * 2006-04-11 2007-10-12 Fond Irccs Istituto Di Ricovero E Cura ... USE OF AMINAHTONE FOR THE PREPARATION OF A MEDICATION FOR THE TREATMENT OF ARTERIOPATHY
TWI539975B (en) * 2009-11-12 2016-07-01 學校法人日本大學 Matrix-type patch preparation and method for producing same
KR101785970B1 (en) 2015-12-04 2017-10-17 연세대학교 원주산학협력단 Pharmaceutical composition for the prevention or treatment of muscle loss comprising Oleic acid or pharmaceutically acceptable salts thereof as an active ingredient

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1499546A (en) * 1974-05-07 1978-02-01 Richter Gedeon Vegyeszet Indolo-quinolizidine derivatives and a process for the preparation thereof
US4353911A (en) * 1979-07-20 1982-10-12 Andre Buzas Indolo(2,3-a)quinolizidines, useful in increasing femoral and vertebral blood flow
HU194221B (en) * 1985-04-19 1988-01-28 Richter Gedeon Vegyeszet Process for preparing novel octahydro-indolo/2,3-a/quinoline derivative and pharmaceutical comprising this compound
US5795909A (en) * 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
JP2000351738A (en) * 1999-06-08 2000-12-19 Lion Corp Drug for external use
JP2001131085A (en) * 1999-08-25 2001-05-15 Saitama Daiichi Seiyaku Kk Medicinal composition for transdermal and transmucosal absorption

Also Published As

Publication number Publication date
WO2003094917A1 (en) 2003-11-20
JPWO2003094917A1 (en) 2005-09-08

Similar Documents

Publication Publication Date Title
HK1084590A1 (en) Pharmaceutical composition for transdermal or transmucosal administration
AU2003291103A1 (en) Pharmaceutical composition
AU2003211376A1 (en) Drug administration method
AU2003221770A1 (en) Controlled release transdermal drug delivery
AU2003278393A1 (en) New use for pharmaceutical composition
AU2003268087A1 (en) Liposomal gemcitabine compositions for better drug delivery
AU2003276656A1 (en) Transdermal delivery system for anti-emetic medication
AU2003223005A1 (en) Application device for topical administration of pharmaceutical agents
AU2003250372A1 (en) Pharmaceutical composition
AU2003246978A1 (en) Pharmaceutical compositions comprising cyclosporin for oral administration
AU2003260803A1 (en) Sustained release pharmaceutical composition
AU2003245504A1 (en) Pharmaceutical compositions for drugs having ph-dependentsolubility
AU2002364468A1 (en) Solid orally-dispersible pharmaceutical formulation
AU5460800A (en) Pharmaceutical transdermal compositions
AU2003241134A1 (en) Transdermal drug delivery system
AU2003284460A1 (en) Medicinal composition
AU2003235931A1 (en) Vintoperol-containing medicinal composition for transdermal administration
AU2003280799A1 (en) Medicinal composition
AU2003252337A1 (en) Patch for transdermal administration
AU2003251643A1 (en) Pharmaceutical compositions containing keto-acids for endoperitoneal administration
AU2003242235A1 (en) Antifungal medicinal composition
AU2003280678A1 (en) Medicinal composition
AU2003244092A1 (en) 1ss-METHYLCARBAPENEM DERIVATIVE FOR ORAL ADMINISTRATION
AU2003230034A1 (en) Transdermal delivery device for the administration of fentanyl
AU2003257814A1 (en) Medicinal composition for lowering blood lipid level

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 18, NO 2, PAGE(S) 590 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME TAKATA SEIYAKU CO., LTD., APPLICATION NO. 2003235931, UNDER INID (43) CORRECT THE PUBLICATION DATE TO READ 24.11.2003